European Journal of Chemistry 2013, 4(2), 172-175. doi:10.5155/eurjchem.4.2.172-175.765

Evaluation of over the counter vaginal lubricants Nonoxynol-9 and KY Jelly as potential inducer of proinflammatory cytokines in human immune cells


Aladin Siddig (1,*) , Richard Addo (2) , Kwame Yeboah (3)

(1) University of Charleston School of Pharmacy, Charleston, WV 25304, USA
(2) Union University School of Pharmacy, Jackson, TN 38305, USA
(3) Harding University College of Pharmacy, Arkansas 72149, USA
(*) Corresponding Author

Received: 04 Mar 2013, Accepted: 30 Mar 2013, Published: 30 Jun 2013

Abstract


Topical microbicides such as Nonoxynol-9 (N9) and KY jelly have been used as vaginal microbicides in clinical trials as anti-HIV-1 products. The objective of this study was to determine if the use of these microbicides may cause production of proinflammatory cytokines in vitro. Such cytokines include, tumor necrosis factor-α (TNF-α), interlukin-1β (IL-1β), interlukin-6 (IL-6), and Interlukin-8 (IL-8). Cellular viability was determined for the peripheral blood mononuclear cells (PBMCs) and Macrophages by culturing them for 24 hours in the presence of serial dilutions of product or placebo. Product and placebo dilutions that gave culture viabilities of ≥ 60% compared to control cultures were considered to be nontoxic. The non-toxic dilutions were 1:100 for KY jelly in both PBMCs and Macrophages. Whereas, the non-toxic dilutions were 1:1000 for N9 in both PBMCs and Macrophages. The values of IL1β, TNF-α, were 0.1 < 2.0 pg/mL for both PBMCs and macrophages. The levels of IL-8 ranged between 9-13 pg/mL and 12-16 pg/mL for PBMCs and macrophages, respectively. The levels of IL-6 were 0.11 g/mL and 0.019 pg/mL for PBMCs and macrophages, respectively. The results were not statistically significant in difference for IL-1β, IL-6, and IL-8 (p > 0.001) when N9 was compared to KY jelly. However, the results were significant when comparing N9 to KY jelly for TNF-α (p < 0.001) production. The two microbicides tested in their non-toxic formulation in the two models of PBMCs and macrophages showed relatively low levels of IL-1b, TNF-α and IL-6. This indicated safety and low toxicity of these microbicide in terms of cytokines release. On the other hand, IL-8 has shown relatively higher levels in all microbicide tested in their non-toxic formulation.

4_2_172_175

Keywords


KY Jelly; Nonoxymol-9; Vaginal Lubricants; Anti-HIV-1 products; Topical Microbicides; Proinflammatory cytokines

Full Text:

PDF /    /


DOI: 10.5155/eurjchem.4.2.172-175.765

Article Metrics


This Abstract was viewed 734 times | PDF Article downloaded 177 times

References

[1]. Who Notes and News, HIV/AIDS, World Health Forum 1997, 18(3-4), 369-372.
PMid:9478164

[2]. Bird, K. D. AIDS 1991, 5, 791-796.
http://dx.doi.org/10.1097/00002030-199107000-00001
PMid:1654056

[3]. Stephenson, J. JAMA 2000, 284, 949-949.
http://dx.doi.org/10.1001/jama.284.8.949
PMid:10944622

[4]. Zacharapoulos, V.; Phillips, D. Clin. Diagn. Lab. Immunol. 1997, 4(4), 465-468.

[5]. Baron, S.; Poast, J.; Nguyen, D.; Cloyd, M. W. AIDS Res. Hum. Retroviruses 2001, 17, 997-1002.
http://dx.doi.org/10.1089/088922201300343672
PMid:11485616

[6]. Milman, G.; Sharma, O. AIDS Res. Hum. Retroviruses 1994, 10, 1305-1312.
http://dx.doi.org/10.1089/aid.1994.10.1305
PMid:7848686

[7]. Bomsel, M. Nat. Med. 1997, 3, 42-47.
http://dx.doi.org/10.1038/nm0197-42
PMid:8986739

[8]. Zacharopoulos, V. R.; Phillips, D. M. Microb. Pathog. 1997, 23, 225-233.
http://dx.doi.org/10.1006/mpat.1997.0151
PMid:9344783

[9]. Phillips, D. M.; Bourinbaiar, A. S. Virology 1992, 186, 261-273.
http://dx.doi.org/10.1016/0042-6822(92)90080-9

[10]. Tan, X.; Phillips, D. M. Arch. Virol. 1996, 141, 1177-1189.
http://dx.doi.org/10.1007/BF01718823
PMid:8774680

[11]. Smith, P. D.; Li, L.; Meng, G. J. Infect. Dis. 1999, 179, S436-S440.
http://dx.doi.org/10.1086/314812
PMid:10099114

[12]. Kabat, D.; Kozak, S. L.; Wehrly, K.; Chesebro, B. J. Virol. 1994, 68, 2570-2577.

[13]. Ariyoshi, K.; Harwood, E.; Chiengsong-Popov, R.; Weber, J. Lancet 1992, 340, 1257-1258.
http://dx.doi.org/10.1016/0140-6736(92)92953-D

[14]. Clark, S. J.; Saag, M. S.; Decker, W. D. Campbell-Hill, S.; Roberson, J. L.; Veldkamp, P. J.; Kappes, J. C.; Hahn, B. H.; Shaw, G. M. N. Engl. J. Med. 1991, 324, 954-960.
http://dx.doi.org/10.1056/NEJM199104043241404
PMid:1900576

[15]. Daar, E. S.; Moudgil, T.; Meyer, R. D.; Ho, D. D. N. Engl. J. Med. 1991, 324, 961-964.
http://dx.doi.org/10.1056/NEJM199104043241405
PMid:1823118

[16]. Connick, E.; Marr, D. G.; Zhang, X. Q.; Clark, S. J.; Saag, M. S.; Schooley, R. T.; Curiel, T. J. AIDS Res. Hum. Retroviruses 1996, 12, 1129-1140.
http://dx.doi.org/10.1089/aid.1996.12.1129
PMid:8844017

[17]. Lawn, S. D.; Subbarao, S.; Wright, Jr. T. C.; Evans-Strickfaden, T.; Ellerbrock, T. V.; Lennox, J. L.; Butera, S. T.; Hart, C. E. J. Infec. Diseases 2000, 181, 1950-1956.
http://dx.doi.org/10.1086/315514
PMid:10837174

[18]. Sykes, J. A.; Whitescarver, J.; Jernstrom, P.; Nolan, J. F.; Bayatt, P. J. Natl. Cancer Inst. 1970, 45, 107-122.

[19]. Huramato, H. Acta Obstet. Gynaecol. Jpn. 1972, 19, 47-58.

[20]. Fogh, J.; Wright, W. C.; Loveless, J. D. J. Natl. Cancer Inst. 1977, 58, 209-214.

[21]. Jennings, R.; Clegg, A. J. Antimicrob. Chemother. 1993, 32, 71-82.
http://dx.doi.org/10.1093/jac/32.1.71

[22]. Malkovsky, M.; Newell, A.; Dalgleish, A. G. Lancet 1988, 1, 645-645.
http://dx.doi.org/10.1016/S0140-6736(88)91440-7

[23]. Patton, D. L.; Kidder, G. G.; Sweeney, Y. C.; Rabe, L. K.; Clark, A. M.; Hillier, S. L. Sex. Transm. Dis. 1996, 23, 461-464.
http://dx.doi.org/10.1097/00007435-199611000-00004
PMid:8946629

[24]. Stafford, M. K.; Ward, H.; Flanagan, A.; Rosenstein, I. J.; Taylor-Robinson, D.; Smith, J. R.; Weber, J.; Kitchen, V. S. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1998, 17, 327-331.
http://dx.doi.org/10.1097/00042560-199804010-00006

[25]. Van Damme, L.; Ramjee, G.; Alary, M.; Vuylsteke, B.; Chandeying, V.; Rees, H.; Sirivongrangson, P.; Mukenge-Tshibaka, L.; Ettiegne-Traore, V.; Uaheowitchai, C.; Karim, S. S.; Masse, B.; Perriens, J.; Laga, M. Lancet 2002, 360, 971-977.
http://dx.doi.org/10.1016/S0140-6736(02)11079-8

[26]. Patton, D. L.; Cosgrove Sweeney, Y. T.; Rabe, L. K.; Hillier, S. L. Sex. Transm. Dis. 2002, 29, 581-587.
http://dx.doi.org/10.1097/00007435-200210000-00004
PMid:12370525

[27]. Phillips, D. M.; Taylor, C. L.; Zacharopoulos, V. R.; Maguire, R. A. Contraception 2000, 62, 149-154.
http://dx.doi.org/10.1016/S0010-7824(00)00156-6

[28]. Fichorova, R. N.; Zhou, F.; Ratnam, V.; Atanssova, V.; Jiang, S.; Strick, N.; Neurath, A. R. Antimicrob. Agents Ch. 2005, 323-335.
PMid:15616312 PMCid:538889

[29]. Centers for Disease Control and Prevention (CDC). National Center for HIV, STD and TB prevention. August 2000.

[30]. Fichorova, R. N.; Tucker, L. D.; Anderson, D. J. J. Inect. Dis. 2001, 184(4), 418-428.
http://dx.doi.org/10.1086/322047
PMid:11471099


How to cite


Siddig, A.; Addo, R.; Yeboah, K. Eur. J. Chem. 2013, 4(2), 172-175. doi:10.5155/eurjchem.4.2.172-175.765
Siddig, A.; Addo, R.; Yeboah, K. Evaluation of over the counter vaginal lubricants Nonoxynol-9 and KY Jelly as potential inducer of proinflammatory cytokines in human immune cells. Eur. J. Chem. 2013, 4(2), 172-175. doi:10.5155/eurjchem.4.2.172-175.765
Siddig, A., Addo, R., & Yeboah, K. (2013). Evaluation of over the counter vaginal lubricants Nonoxynol-9 and KY Jelly as potential inducer of proinflammatory cytokines in human immune cells. European Journal of Chemistry, 4(2), 172-175. doi:10.5155/eurjchem.4.2.172-175.765
Siddig, Aladin, Richard Addo, & Kwame Yeboah. "Evaluation of over the counter vaginal lubricants Nonoxynol-9 and KY Jelly as potential inducer of proinflammatory cytokines in human immune cells." European Journal of Chemistry [Online], 4.2 (2013): 172-175. Web. 16 Sep. 2019
Siddig, Aladin, Addo, Richard, AND Yeboah, Kwame. "Evaluation of over the counter vaginal lubricants Nonoxynol-9 and KY Jelly as potential inducer of proinflammatory cytokines in human immune cells" European Journal of Chemistry [Online], Volume 4 Number 2 (30 June 2013)

DOI Link: https://doi.org/10.5155/eurjchem.4.2.172-175.765

Refbacks

  • There are currently no refbacks.




Copyright (c)




© Copyright 2019  Atlanta Publishing House LLC All Right Reserved.

The opinions expressed in all articles published in European Journal of Chemistry are those of the specific author(s), and do not necessarily reflect the views of Atlanta Publishing House LLC, or European Journal of Chemistry, or any of its employees.

Copyright 2019 Atlanta Publishing House LLC. All rights reserved. This site is owned and operated by Atlanta Publishing House LLC whose registered office is 4614 Lavista road, Tucker, GA, 30084, USA. Registered in USA.